NCT05934539 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05934539
Title	ALG.APV-527 First-in-human Study
Recruitment	Unknown status
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Aptevo Therapeutics
Indications	pancreatic cancer renal cell carcinoma endometrial cancer lung non-small cell carcinoma stomach cancer colorectal cancer cervical cancer prostate cancer breast cancer transitional cell carcinoma head and neck squamous cell carcinoma malignant pleural mesothelioma gastroesophageal cancer ovarian cancer
Therapies	ALG.APV-527
Age Groups:	senior \| adult
Covered Countries	USA

NCT05934539
Clinical Trial Detail